Vivisco

Developing the next generation of medical devices and consumer products to leverage the potential of photosensitisers.

Problem

Multiple light-activated drugs have been developed. They have shown effectiveness in treating a range of diseases. However, these light-activated drugs have had limited impact on global and consumer health due to the delivery of light to these drugs in the body

Solution

Using microscale engineering, we use functional LED and sensor technology to activate and measure light-active drugs for therapeutics, diagnostics and consumer products. Our first therapeutic focus is delivering photoactivation therapy for the treatment of viral and bacterial infections.

Team

• Alastair Kirby – CEO
• Dr Christopher Russell – CTO

UN Sustainable Development Goals